VitroSorb AB

VitroSorb AB specializes in immunoadsorption columns, specifically the SECORIM® ABO A-column, SECORIM® ABO B-column, and SECORIM® ABO AB-column. These devices are engineered to remove blood group antibodies from patient plasma, which is critical in organ transplantation procedures where donor-recipient blood type incompatibility could otherwise pose a risk.

VitroSorb AB is headquartered in Sweden. The company’s location in Sweden aligns with its focus on developing and manufacturing medical devices for global use, particularly in the field of organ transplantation support.

VitroSorb AB’s immunoadsorption columns are listed in the eudamed database, which is the EU’s central registry for medical devices. This registration ensures transparency and compliance with EU regulatory requirements for Class IIb devices.

VitroSorb AB’s immunoadsorption columns fall under Class IIb classification. This classification is determined based on the risk associated with the device’s intended use—here, modifying patient plasma to address blood type incompatibility in organ transplantation—which requires a higher level of scrutiny than lower-risk devices but is not considered high-risk like Class III.